Dipharma Francis S.r.l
Matteo Panza is a skilled professional in the field of chemistry, currently serving as a Process Development Scientist at Dipharma Francis Srl since January 2023. Prior to this role, Matteo held positions as a Scientist at Dipharma, Inc. from March 2022 to January 2023 and at Cayman Chemical from March 2020 to March 2022, focusing on the development of new catalog products and custom synthesis while contributing to structure-activity relationship studies. Matteo gained valuable experience as a Research Assistant at the University of Missouri-Saint Louis from January 2015 to December 2019, where responsibilities included training undergraduate students and mentoring graduate students. Educational qualifications include a PhD and MS in Chemistry from the University of Missouri-Saint Louis, as well as an MS and BS in Chemical Sciences and Chemistry from Università degli Studi di Milano.
This person is not in any teams
This person is not in any offices
Dipharma Francis S.r.l
1 followers
The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by a fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.